ME

MedPlus Health Services LtdNSE MEDPLUS Stock Report

Last reporting period 31 Mar, 2024

Updated 01 Nov, 2024

Last price

Market cap $B

1.592

Small

Exchange

XNSE - National Stock Exchange Of India

MEDPLUS.NS Stock Analysis

ME

Uncovered

MedPlus Health Services Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

36/100

Low score

Market cap $B

1.592

Dividend yield

Shares outstanding

119.54 B

MedPlus Health Services Ltd. engages in the operation of pharmacies. The company is headquartered in Hyderabad, Telangana and currently employs 21,000 full-time employees. The company went IPO on 2021-12-23. The firm is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. The company operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The firm operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.

View Section: Eyestock Rating